Datapoint

Datapoint: Alignment Healthcare Proposes IPO

Medicare Advantage (MA) startup Alignment Healthcare last week filed a registration statement on Form S-1 with the Securities and Exchange Commission, signaling that the insurer is preparing to launch an initial p...
0 Comments

Datapoint: Actemra Scores Systemic Sclerosis Nod

The FDA last week cleared Genentech’s Actemra for the treatment of systemic sclerosis, a rare autoimmune disease occurring in patients with interstitial lung disease. The drug is the first biologic approved for ...
0 Comments

Datapoint: InnovAge Launches IPO

InnovAge Holding Corp., a Denver-based insurer that focuses on seniors who are dually eligible for Medicare and Medicaid, on Feb. 24 announced the launch of its initial public offering. The company will be listed ...
0 Comments

Datapoint: Centene Snags Hawaii Medicaid Contract Renewal

Centene Corp. last week said its Hawaii subsidiary, ‘Ohana Health Plan, was selected by the Hawaii Department of Human Services to continue proving behavioral health services to the state’s Medicaid managed ca...
0 Comments

Datapoint: Aetna Contests Oklahoma Medicaid Awards

CVS Health Corp.’s Aetna Better Health of Oklahoma is protesting its exclusion from the Oklahoma Health Care Authority’s recent Medicaid contract awards, alleging the process was legally unsound and violated ...
0 Comments

Datapoint: New York Approves Highmark-HealthNow Combination

The state of New York last week approved Highmark Health and HealthNow New York’s affiliation deal, provided certain conditions, including job protection and health equity standards, are met. While deal is being...
0 Comments

Datapoint: Libtayo Scores NSCLC Nod, Will Take On Keytruda

Sanofi and Regeneron’s Libtayo last week scored its third FDA approval, this time for first-line treatment of advanced non-small cell lung cancer (NSCLC) in patients whose tumors have high PD-L1 expression. The d...
0 Comments

Datapoint: Court Ruling Clears Path for North Carolina Medicaid Transformation

A North Carolina superior court judge last week upheld an earlier ruling that dismissed requests to halt the state’s Medicaid managed care transformation, which has been in limbo since contracts were awarded in ...
0 Comments

Datapoint: Regeneron’s Evkeeza Scores First-in-Class Approval for Ultra-Rare Heart Disease

The FDA on Feb. 11 approved Regeneron Pharmaceuticals, Inc.’s Evkeeza as an adjunct treatment to other low-density lipoprotein lowering therapies in patients 12 and older with homozygous familial hypercholestero...
0 Comments

Datapoint: Commonwealth Care Alliance to Expand Mass. Duals Demo

Boston-based community health org Commonwealth Care Alliance last week said it is expanding its One Care plan, a joint demonstration project with CMS that serves Medicare-Medicaid dual eligibles, into Berkshire Co...
0 Comments